EBI-话题@MedSci

#EBI#

97篇内容 | 2653人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997140, encodeId=e20e199e14083, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：脱碘酶-3是一种调节足细胞稳态的甲状腺调节剂, objectType=article, longId=221625, objectId=ec3322162530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec3322162530, replyNumber=0, likeNumber=94, createdTime=2022-05-13, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec3322162530, moduleTitle=EBioMedicine：脱碘酶-3是一种调节足细胞稳态的甲状腺调节剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec3322162530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997141, encodeId=6c63199e141af, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：轻度至中度COVID-19患者行下一代血浆蛋白质组分析的相关研究, objectType=article, longId=265039, objectId=f0912650397e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0912650397e, replyNumber=0, likeNumber=71, createdTime=2022-01-02, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0912650397e, moduleTitle=EBioMedicine：轻度至中度COVID-19患者行下一代血浆蛋白质组分析的相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0912650397e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997136, encodeId=bb5e199e136f6, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=Ferring和Rebiotix呈报的标志性3期数据显示，在研RBX2660减少艰难梭菌反复感染的有效性优于安慰剂, objectType=article, longId=211818, objectId=768c211818c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=768c211818c9, replyNumber=0, likeNumber=85, createdTime=2021-06-28, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=768c211818c9, moduleTitle=Ferring和Rebiotix呈报的标志性3期数据显示，在研RBX2660减少艰难梭菌反复感染的有效性优于安慰剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=768c211818c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997132, encodeId=fc8d199e13254, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：粪便微生物群移植可显著改善肠易激综合症患者的生活质量, objectType=article, longId=204216, objectId=156a20421630, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=156a20421630, replyNumber=0, likeNumber=83, createdTime=2021-05-09, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=156a20421630, moduleTitle=EBioMedicine：粪便微生物群移植可显著改善肠易激综合症患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=156a20421630)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997139, encodeId=bbee199e13958, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle= EBioMedicine：母乳喂养或能降低婴儿患糖尿病风险, objectType=article, longId=218903, objectId=f3e22189037a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3e22189037a, replyNumber=0, likeNumber=72, createdTime=2022-05-21, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3e22189037a, moduleTitle= EBioMedicine：母乳喂养或能降低婴儿患糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3e22189037a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997134, encodeId=458b199e134da, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：“先有鸡还是先有蛋？”2型糖尿病患者胰岛素水平升高或先于胰岛素抵抗发生, objectType=article, longId=208478, objectId=16482084e8b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16482084e8b4, replyNumber=0, likeNumber=92, createdTime=2022-02-28, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16482084e8b4, moduleTitle=EBioMedicine：“先有鸡还是先有蛋？”2型糖尿病患者胰岛素水平升高或先于胰岛素抵抗发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16482084e8b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997130, encodeId=de3a199e130ec, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=Bluebird突破性基因疗法Lenti-D申请上市！改善致死罕见病CALD患者长期生存结局, objectType=article, longId=201693, objectId=ec9320169308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec9320169308, replyNumber=0, likeNumber=70, createdTime=2020-12-31, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec9320169308, moduleTitle=Bluebird突破性基因疗法Lenti-D申请上市！改善致死罕见病CALD患者长期生存结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9320169308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997133, encodeId=d38b199e13375, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=基因治疗出岔子了？蓝鸟(Bluebird Bio)暂停LentiGlobin基因疗法1/2、3期临床研究, objectType=article, longId=207233, objectId=008b20e23326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=008b20e23326, replyNumber=0, likeNumber=80, createdTime=2021-09-26, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=008b20e23326, moduleTitle=基因治疗出岔子了？蓝鸟(Bluebird Bio)暂停LentiGlobin基因疗法1/2、3期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=008b20e23326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997126, encodeId=912b199e1266d, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：新冠候选疫苗初见成效，即将进入临床试验阶段！, objectType=article, longId=191410, objectId=e0b71914103a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0b71914103a, replyNumber=0, likeNumber=65, createdTime=2021-01-25, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0b71914103a, moduleTitle=EBioMedicine：新冠候选疫苗初见成效，即将进入临床试验阶段！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0b71914103a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997129, encodeId=60c1199e12917, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, objectType=article, longId=198710, objectId=a8d7198e10e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d7198e10e3, replyNumber=0, likeNumber=82, createdTime=2020-12-16, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d7198e10e3, moduleTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d7198e10e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997125, encodeId=16da199e1252f, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：胰腺癌转移倾向的关键机制, objectType=article, longId=190104, objectId=e6d919010455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d919010455, replyNumber=0, likeNumber=81, createdTime=2021-02-25, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d919010455, moduleTitle=EBioMedicine：胰腺癌转移倾向的关键机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d919010455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997124, encodeId=3953199e1243b, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：胰腺癌应该存在可有的驱动基因突变, objectType=article, longId=190103, objectId=e0c5190103bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0c5190103bf, replyNumber=0, likeNumber=81, createdTime=2020-05-28, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0c5190103bf, moduleTitle=EBioMedicine：胰腺癌应该存在可有的驱动基因突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0c5190103bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997131, encodeId=69bb199e13111, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：细胞外分泌的烟酰胺磷酸肌转移酶（eNAMPT）在前列腺癌进展中的作用, objectType=article, longId=202456, objectId=f60e202456b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f60e202456b3, replyNumber=0, likeNumber=76, createdTime=2021-02-06, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f60e202456b3, moduleTitle=EBioMedicine：细胞外分泌的烟酰胺磷酸肌转移酶（eNAMPT）在前列腺癌进展中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f60e202456b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997128, encodeId=5342199e12890, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：辟谣！南加州大学研究：鱼类中的ω-3脂肪酸并不能预防阿尔茨海默症！, objectType=article, longId=197848, objectId=3c7a19e84851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c7a19e84851, replyNumber=0, likeNumber=92, createdTime=2020-08-29, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c7a19e84851, moduleTitle=EBioMedicine：辟谣！南加州大学研究：鱼类中的ω-3脂肪酸并不能预防阿尔茨海默症！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c7a19e84851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997123, encodeId=7105199e123ab, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine: 与T2D有关的肠道菌群种类, objectType=article, longId=189915, objectId=af8a18991554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af8a18991554, replyNumber=0, likeNumber=63, createdTime=2020-07-05, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af8a18991554, moduleTitle=EBioMedicine: 与T2D有关的肠道菌群种类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af8a18991554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997127, encodeId=9352199e127db, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：Thbs1——可能是非酒精性脂肪肝的新型生物标志物与治疗靶点, objectType=article, longId=196398, objectId=4599196398bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4599196398bf, replyNumber=0, likeNumber=85, createdTime=2020-09-01, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4599196398bf, moduleTitle=EBioMedicine：Thbs1——可能是非酒精性脂肪肝的新型生物标志物与治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4599196398bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997118, encodeId=c648199e1185f, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBiolMed：上海交通大学提出基于信号通路的肝癌风险预测模型, objectType=article, longId=174458, objectId=5ffe1e44584c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ffe1e44584c, replyNumber=0, likeNumber=77, createdTime=2020-06-12, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ffe1e44584c, moduleTitle=EBiolMed：上海交通大学提出基于信号通路的肝癌风险预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ffe1e44584c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997120, encodeId=c597199e12017, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究, objectType=article, longId=178845, objectId=88551e8845db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88551e8845db, replyNumber=0, likeNumber=75, createdTime=2020-01-09, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88551e8845db, moduleTitle=头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88551e8845db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997119, encodeId=02cf199e1198c, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化, objectType=article, longId=177980, objectId=fe551e798093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe551e798093, replyNumber=0, likeNumber=74, createdTime=2020-04-22, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe551e798093, moduleTitle=FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe551e798093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997122, encodeId=15c1199e12256, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=第61届ASH：bluebird bio将展示其基因和细胞疗法的全新数据, objectType=article, longId=182555, objectId=4dc11825558b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dc11825558b, replyNumber=0, likeNumber=65, createdTime=2020-01-25, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dc11825558b, moduleTitle=第61届ASH：bluebird bio将展示其基因和细胞疗法的全新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dc11825558b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EBI

2020-05-29

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：脱碘酶-3是一种调节足细胞稳态的甲状腺调节剂

2022-05-13

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：轻度至中度COVID-19患者行下一代血浆蛋白质组分析的相关研究

2022-01-02

linagood (审核中...)

前往app查看评论内容

#EBI#

Ferring和Rebiotix呈报的标志性3期数据显示，在研RBX2660减少艰难梭菌反复感染的有效性优于安慰剂

2021-06-28

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：粪便微生物群移植可显著改善肠易激综合症患者的生活质量

2021-05-09

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：母乳喂养或能降低婴儿患糖尿病风险

2022-05-21

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：“先有鸡还是先有蛋？”2型糖尿病患者胰岛素水平升高或先于胰岛素抵抗发生

2022-02-28

linagood (审核中...)

前往app查看评论内容

#EBI#

Bluebird突破性基因疗法Lenti-D申请上市！改善致死罕见病CALD患者长期生存结局

2020-12-31

linagood (审核中...)

前往app查看评论内容

#EBI#

基因治疗出岔子了？蓝鸟(Bluebird Bio)暂停LentiGlobin基因疗法1/2、3期临床研究

2021-09-26

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：新冠候选疫苗初见成效，即将进入临床试验阶段！

2021-01-25

linagood (审核中...)

前往app查看评论内容

#EBI#

Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌

2020-12-16

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：胰腺癌转移倾向的关键机制

2021-02-25

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：胰腺癌应该存在可有的驱动基因突变

2020-05-28

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：细胞外分泌的烟酰胺磷酸肌转移酶（eNAMPT）在前列腺癌进展中的作用

2021-02-06

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：辟谣！南加州大学研究：鱼类中的ω-3脂肪酸并不能预防阿尔茨海默症！

2020-08-29

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine: 与T2D有关的肠道菌群种类

2020-07-05

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：Thbs1——可能是非酒精性脂肪肝的新型生物标志物与治疗靶点

2020-09-01

linagood (审核中...)

前往app查看评论内容

#EBI#

EBiolMed：上海交通大学提出基于信号通路的肝癌风险预测模型

2020-06-12

linagood (审核中...)

前往app查看评论内容

#EBI#

头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究

2020-01-09

linagood (审核中...)

前往app查看评论内容

#EBI#

FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化

2020-04-22

linagood (审核中...)

前往app查看评论内容

#EBI#

第61届ASH：bluebird bio将展示其基因和细胞疗法的全新数据

2020-01-25

科室
- - 订阅+
  - 更多科室
工具
服务